|
New literature release from AbD Serotec
HuCAL®
Antibodies Technical Manual
This valuable 84-page publication describes the principles behind HuCAL recombinant antibodies, the basis of their exceptional specificity, and presents protocols, examples, and troubleshooting tips for their use in applications such as ELISA and IP. A free copy is available from AbD Serotec at www.ab-direct.com.
HuCAL technology has been revolutionizing the way monoclonal antibodies are generated for many years, and offers many advantages over traditional animal-based methods – including speed, specificity, and production technology. HuCAL antibodies are selected from a high quality, synthetic library of more than 15 billion expressible antibody specificities. This is the very latest and most powerful library created by MorphoSys, and has already generated thousands of monoclonals for researchers worldwide.
In addition to explaining the key design and construction features of the HuCAL library, the Technical Manual also explains why HuCAL antibodies are preferable to full IgGs, how the selection can be geared to directly generate a monoclonal antibody that can distinguish between a wild-type protein and a single amino acid mutation; and why using the AgX™ Antigen Expression Service can lead to increased specificity and functionality for your antibodies.
MorphoSys develops and applies innovative technologies for the production of synthetic antibodies which accelerate drug discovery and target characterization. Founded in 1992, the Company’s proprietary Human Combinatorial Antibody Library (HuCAL®) technology is used by researchers worldwide for human antibody generation. Additionally, MorphoSys is active in the antibody research market through its AbD Serotec business unit. For further information, please visit the corporate website at www.morphosys.com ; information on MorphoSys’ AbD Serotec is available at www.ab-direct.com .
Key Contact:
John Atkinson
European OEM Manager
Tel: +44 1865 852 700
Email: jatkinson@ab-direct.com |